Literature DB >> 2992527

Selective inhibition of one of the cyclic AMP phosphodiesterases from rat brain by the neurotropic compound rolipram.

G Nemoz, A F Prigent, M Moueqqit, S Fougier, O Macovschi, H Pacheco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2992527     DOI： 10.1016/0006-2952(85)90029-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  Effects of the phosphodiesterase inhibitor rolipram on the acoustic startle response in rats.

Authors:  J H Kehne; N M Boulis; M Davis
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram.

Authors:  H Wachtel; P A Löschmann
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors.

Authors:  T C Rich; T E Tse; J G Rohan; J Schaack; J W Karpen
Journal:  J Gen Physiol       Date:  2001-07       Impact factor: 4.086

4.  Cloning and characterization of mammalian homologs of the Drosophila dunce+ gene.

Authors:  R L Davis; H Takayasu; M Eberwine; J Myres
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 5.  Memory suppressor genes: Modulating acquisition, consolidation, and forgetting.

Authors:  Nathaniel C Noyes; Anna Phan; Ronald L Davis
Journal:  Neuron       Date:  2021-08-26       Impact factor: 18.688

6.  Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions.

Authors:  M Lobban; Y Shakur; J Beattie; M D Houslay
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

7.  Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.

Authors:  M D Ivorra; C Lugnier; C Schott; M Catret; M A Noguera; E Anselmi; P D'Ocon
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

8.  Identification of a B2-bradykinin receptor linked to phospholipase C and inhibition of dopamine stimulated cyclic AMP accumulation in the human astrocytoma cell line D384.

Authors:  A J Balmforth; F E Parkinson; N Altiok; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

9.  Modulation of the cAMP signaling pathway after traumatic brain injury.

Authors:  Coleen M Atkins; Anthony A Oliva; Ofelia F Alonso; Damien D Pearse; Helen M Bramlett; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2007-08-29       Impact factor: 5.330

10.  Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.

Authors:  T J Torphy; M S Barnette; D W Hay; D C Underwood
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.